Atlas Trials

Olanzapine 2.5 vs 5 mg in Quadruplet Nausea/Vomiting Prophylaxis Before High-Dose Melphalan

Clinical trial NCT06588413 · RECRUITING

Trial details

NCT number
NCT06588413
Sponsor
Augusta University
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Multiple MyelomaAutologous Stem Cell Transplantation
Start date
2024-09-17
Primary completion
2027-10-01
Enrollment
172

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.